Evidence map›Paper›PMID 35114959›Full record

ArticleBMC infectious diseases2022

Immunovirological discordance among female sex workers who start antiretroviral therapy in Burkina Faso.

Wilfried Wenceslas Bazié, Diane Yirgnur Somé, Isidore Tiandiogo Traoré, Anselme Sanon, Issouf Konaté, Souleymane Tassembedo, Ajani Ousmane Taofiki, Dramane Kania, Abdoulaye Ouédraogo, Bea Vuylsteke and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 8 countries.

Wilfried Wenceslas Bazié *Centre Muraz, Institut National de Santé Publique, 2054 Avenue Mamadou Konaté01 BP 390, Bobo-Dioulasso, Burkina Faso. bww_wens@yahoo.fr.
Diane Yirgnur Somé *Centre Muraz, Institut National de Santé Publique, 2054 Avenue Mamadou Konaté01 BP 390, Bobo-Dioulasso, Burkina Faso.
Isidore Tiandiogo TraoréCentre Muraz, Institut National de Santé Publique, 2054 Avenue Mamadou Konaté01 BP 390, Bobo-Dioulasso, Burkina Faso.
Anselme SanonCentre Muraz, Institut National de Santé Publique, 2054 Avenue Mamadou Konaté01 BP 390, Bobo-Dioulasso, Burkina Faso.
Issouf KonatéCentre Muraz, Institut National de Santé Publique, 2054 Avenue Mamadou Konaté01 BP 390, Bobo-Dioulasso, Burkina Faso.
Souleymane TassembedoCentre Muraz, Institut National de Santé Publique, 2054 Avenue Mamadou Konaté01 BP 390, Bobo-Dioulasso, Burkina Faso.
Ajani Ousmane TaofikiCentre Muraz, Institut National de Santé Publique, 2054 Avenue Mamadou Konaté01 BP 390, Bobo-Dioulasso, Burkina Faso.
Dramane KaniaCentre Muraz, Institut National de Santé Publique, 2054 Avenue Mamadou Konaté01 BP 390, Bobo-Dioulasso, Burkina Faso.
Abdoulaye OuédraogoCentre Muraz, Institut National de Santé Publique, 2054 Avenue Mamadou Konaté01 BP 390, Bobo-Dioulasso, Burkina Faso.
Bea VuylstekeDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Caroline GilbertAxe de Recherche Maladies Infectieuses et Immunitaires, Centre de Recherche du CHU de Québec-Université Laval, Québec, QC, Canada.
Nicolas MedaCentre Muraz, Institut National de Santé Publique, 2054 Avenue Mamadou Konaté01 BP 390, Bobo-Dioulasso, Burkina Faso.
Abdoul Salam OuédraogoInstitut Supérieur des Sciences de la Santé, Université Nazi Boni, Bobo-Dioulasso, Burkina Faso.
Nicolas NagotINSERM, Université des Antilles, Etablissement Français du Sang, Montpellier, France.
Centre Muraz · BFNazi Boni University · BFPublic Health Institute · USUniversité des Antilles · GPUniversité Laval · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn people living with HIV/AIDS (PLWHA), initiation of antiretroviral therapy (ART) leads to sustained effective suppression of viral replication and increasing CD4 + T cell count. However, a fraction of ART-treated patients still fail to reach adequate CD4 + T cell number despite a suppressed viral load (VL), and this phenomenon is defined as immunovirological discordance (IVD). In Africa, several studies have reported immunovirological outcomes of antiretroviral therapy, but little is known about IVD occurrence in Female sex workers (FSW). This study aimed to assess the prevalence of IVD and associated factors among a cohort of HIV infected FSW in Burkina Faso.

methodsWe conducted a cohort study from December 2003 to October 2016. Immunovirological discordance was defined as CD4 + T cell gain < 100 cells/µL despite a suppressed VL (VL < 1000 copies/mL) 12 months after ART initiation. The CD4 + T cells were counted using BD FACSCount™ System and point of care Pima™ CD4 + Analyzer. HIV-1 RNA was quantified by real-time polymerase-chain-reaction assay with the use of the ABI 7000 system. We conducted a logistic regression to identify factors associated with discordant responses.

resultsAmong the 123 HIV-1 infected FSW having at least 12 months follow-up on ART, 105 (85.4%) achieved HIV-1 RNA suppression. Among the latter 25 gained less than 100 CD4 + T cells within 12 months follow-up. The IVD rate was 23.8% (95%CI 16.04%-33.11%). After adjustment for age, WHO clinical stage and ART regimen including nucleoside/nucleotide reverse transcriptase inhibitors, only baseline CD4 + T cell count between 200 to 350 cells/µL (adjusted OR: 4.15; 95%CI 1.13-15.22) and 350 to 500 cells/µL (adjusted OR: 17.50; 95%CI 2.68-114.31) remain significantly associated with IVD occurrence.

conclusionsImmunovirological discordance response was common in FSW with proportions close to those observed in the general population. A diagnosis and personalized follow-up of patients who do not achieve full immune reconstitution would make it possible to avoid complications in terms of morbidity and mortality.

Indexed as

Anti-HIV AgentsHIV InfectionsSex WorkersBurkina FasoCD4 Lymphocyte CountCohort StudiesFemaleHumansViral LoadWorld Health OrganizationAnti-HIV AgentsAntiretroviral therapyBurkina FasoFemale sex workersHIV-1Immunovirological discordance

Identifiers

PMID35114959
PMCPMC8812047
OpenAlexW4210533606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.